Access cutting-edge venous thromboembolism treatment through this phase 4 clinical trial at a research site in Syracuse. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Syracuse location
Preparing your pre-screening questions…
Access venous thromboembolism specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related venous thromboembolism treatment provided free
Check if you qualify for this venous thromboembolism clinical trial in Syracuse, NY
No-Cost Study Care
Local to Syracuse
Convenient for NY residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The goal of this clinical trial is to learn if apixaban (a pill) is a safe and easier alternative to taking enoxaparin (a daily shot) to prevent blood clots after head and neck cancer surgery. It will also learn about side effects of both medicines. The main questions it aims to answer are: Can apixaban be used safely instead of enoxaparin to prevent blood clots after surgery? Do patients find apixaban easier or more satisfying to take than enoxaparin? How well do patients follow the treatment plan with each medicine? Researchers will compare 2 groups: One group will take apixaban (a pill taken twice a day) for 10 days after surgery. The other group will take enoxaparin (a shot given once a day) for 10 days after surgery. Participants will: Take either apixaban or enoxaparin starting 12-24 hours after surgery, for 10 days total Keep a medication diary and bring back unused medicine so the study team can check adherence Complete short surveys about satisfaction with their medicine Have an ultrasound of their legs to check for blood clots 11-14 days after surgery Return for follow-up visits about 40 days and 80 days after surgery for safety checks How long will participation last? About 4 months from surgery through the last follow-up visit.
Sponsor: Kiranya Arnold
Yes, this clinical trial (NCT07189897) has an active research site in Syracuse, NY that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for venous thromboembolism treatment options in Syracuse, NY, this clinical trial (NCT07189897) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Syracuse research site is actively enrolling participants for this phase 4 clinical trial. You'll receive care from experienced venous thromboembolism specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all venous thromboembolism clinical trials near you to find additional studies recruiting in your area.
See all deep vein thrombosis clinical trials recruiting in Syracuse — not just this study.
Browse Deep Vein Thrombosis Trials in Syracuse →